Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Asthma is a life time chronic disease taking off to abnormal lung functions and difficulty in breathing. The reason that many people fight to control their asthma is frequently due to a lack of self-awareness of symptoms that could specify risk of attack. Self-monitoring is the initial course of action to monitor, treat and control the chronic disease. Self-monitoring jointly supports physicians and patients to have control over real time monitoring and to offer on-time treatment. Furthermore, asthma is a well-understood chronic condition, affecting 25 million people in the U.S., according to the Center for Disease Control (CDC). However, although the CDC has released extensive reports and guidelines on how to control asthma, an estimated 44,000 asthma attacks occur every single day in the U.S. alone. Moreover, currently portable devices are offered to monitor peak expiratory flow. The offered system specifically smart portable monitoring device for Asthma Patients benefits to track real time symptoms of asthma and to make immediate changes in medications. This system includes portable hardware unit to monitor patient’s activity, exhaled air pressure, carbon dioxide content and environment temperature of the asthma patient. Additionally, the system also encompasses of software application, through which physician can have real time track on parameters. In addition, digital technologies and electronic healthcare, represent a major opportunity to rethink various diseases.
The global intelligent asthma monitoring management market is driven by key factors such as increase in indoor air pollutants, constant developments in artificial intelligence and advancement in technology. Furthermore, rise in prevalence of chronic obstructive pulmonary disease (COPD) and asthma and surge in adoption of smart inhalers are also some factors driving the intelligent asthma monitoring management market. However, high cost of devices and lack of reimbursement in developing countries are some factors hampering the market growth.
The intelligent asthma monitoring management market is segmented by product & service, end user and geography
The products & services in this report are devices, asthma monitoring apps and services. The devices segments is further bifurcated into wearable asthma monitoring devices and smart inhalers. The smart inhalers segment is classified into inhalers and nebulizers. Among these, the inhalers segment is bifurcated into dry powder inhalers (DPIs) and metered dose inhalers (MDIs). Furthermore, services segment is bifurcated into remote monitoring, Database Management Services and others. Among these, the growing demand for wireless and wearable devices for disease management and technological innovations in devices are the key factors driving the devices segment globally.
The various end user studied in this report are self/home healthcare, hospitals & specialty clinics and academic & research institutes. The home care monitoring segment dominated the market in 2018, due to the move toward home care & self-management of asthma diseases and advancement in technology.
On the basis of geography, the intelligent asthma monitoring management market is segmented into North America, Europe, Asia-Pacific and Rest of the world. North America region dominated the intelligent asthma monitoring management market in 2018 due to advancement in technology solutions, strong presence of companies from healthcare industry and presence of companies providing intelligent asthma monitoring management solutions in the region.
Some of the major players operating in the intelligent asthma monitoring management market includes Vectura Group plc, Propeller Health, Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), Adherium Limited, Qualcomm Life, AstraZeneca plc, Health Care Originals, Philips Healthcare, GlaxoSmithKline plc, Volansys Technologies, Cohero Health, Inc., Respiri, Quvium, 3M and AEvice Health. Leading companies have invested massive capital in research & development and mergers & acquisitions activities to develop innovative products in the market.
The intelligent asthma monitoring management market is segmented by product & service, end user and geography. The products & services in this report are devices, asthma monitoring apps and services. The devices segments is further bifurcated into wearable asthma monitoring devices and smart inhalers. The smart inhalers segment is classified into inhalers and nebulizers. Among these, the inhalers segment is bifurcated into dry powder inhalers (DPIs) and metered dose inhalers (MDIs). Furthermore, services segment is bifurcated into remote monitoring, Database Management Services and others. Among these, the growing demand for wireless and wearable devices for disease management and technological innovations in devices are the key factors driving the devices segment globally.
The various end user studied in this report are self/home healthcare, hospitals & specialty clinics and academic & research institutes. The home care monitoring segment dominated the market in 2018, due to the move toward home care & self-management of asthma diseases and advancement in technology.
On the basis of geography, the intelligent asthma monitoring management market is segmented into North America, Europe, Asia-Pacific and Rest of the world. North America region dominated the intelligent asthma monitoring management market in 2018 due to advancement in technology solutions, strong presence of companies from healthcare industry and presence of companies providing intelligent asthma monitoring management solutions in the region.
Why to buy this report:
